The effect of methadone on blood glucose, lipids and glucose-modulating hormones in methadone-dependent Wistar rats
Tóm tắt
A growing body of evidence indicates that opioids regulate mechanisms activated during the stress response. This study was aimed to investigate the effect of methadone dependency on blood glucose, lipids and glucose-modulating hormones in male and female Wistar rats.This study was performed on 40 Wistar rats weighing 150–350 g, in four methadone exposure and control groups of both males and females. All rats were weighed at the beginning and end of the study and their fasting blood glucose was measured using a glucometer. In order to induce addiction, methadone was injected intraperitoneal for 10 consecutive days at 5 mg/kg dose. The control group received the same volume of only normal saline. At the end of the study, the rats were sacrificed and their blood serum collected to measure cortisol, glucagon, adrenaline and lipid profile levels.There was a significant decrease in the mean final blood glucose of methadone-treated versus control male rats (p = 0.02). There was no significant glucose difference, however, in female rats. Furthermore, a decrease in the mean serum levels of triglyceride, cortisol, and adrenaline occurred in male rats of methadone-dependent compared with control animals, but there was no significant difference in these values in female rats. Our results showed that methadone significantly reduced serum glucose as well as triglyceride levels only in male rats, this being associated with a reduction in the level of counter-regulating hormones of carbohydrate metabolism. Changes in lipid profiles, however, occurred independently of gender.
Tài liệu tham khảo
Chen C-Y, Lin K-M (2009) Health consequences of illegal drug use. Curr Opin Psychiatry 22:287–292
Ghane T, Zamani N, Hassanian-Moghaddam H, Beyrami A, Noroozi A (2018) Lead poisoning outbreak among opium users in the Islamic Republic of Iran, 2016–2017. Bull World Health Organ 96:165
Najafipour H, Beik A (2016) The impact of opium consumption on blood glucose, serum lipids and blood pressure, and related mechanisms. Front Physiol 7:436
Bozchelou S, Delirrad M (2019) Effects of methadone maintenance therapy on thyroid function of adult men. Toxicol Res 35:9–12
Heimer R, Bray S, Burris S, Khoshnood K, Blankenship KM (2002) Structural interventions to improve opiate maintenance. Int J Drug Policy 13:101–111
Soltaninejad K, Hassanian-Moghaddam H, Shadnia S (2014) Methadone related poisoning on the rise in Tehran. Iran. Asia Pac J Med Toxicol 3:104–109
Flory JH, Wiesenthal AC, Thaler HT, Koranteng L, Moryl N (2016) Methadone use and the risk of hypoglycemia for inpatients with cancer pain. J Pain Symptom Manag 51:79–87
Toce MS, Stefater MA, Breault DT, Burns MM (2018) A case report of methadone-associated hypoglycemia in an 11-month-old male. Clin Toxicol 56:74–76
Faskowitz AJ, Kramskiy VN, Pasternak GW (2013) Methadone-induced hypoglycemia. Cell Mol Neurobiol 33:537–542
Moryl N, Pope J, Obbens E (2013) Hypoglycemia during rapid methadone dose escalation. J Opioid Manag 9:29–34
Droletm G, Dumont EC, Gosselin I, Kinkead R, Laforest S, Trottier JF (2001) Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol Biol Psychiatry 25:729–741
Vuong C, Van Uum SH, Odell LE, Lutfy K, Friedman TC (2009) The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 31:98–132
Karam GA, Reisi M, Kaseb AA, Khaksari M, Mohammadi A, Mahmoodi M (2004) Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus. Addict Biol 9:53–58
Karam GA, Rashidinejad HR, Aghaee MM, Ahmadi J, Rahmani MR, Mahmoodi M, Azin H, Mirzaee MR, Khaksari M (2008) Opium can differently alter blood glucose, sodium and potassium in male and female rats. Pak J Pharm Sci 21:180–184
Park SH, Sim YB, Kang YJ, Kim SM, Lee JK, Jung JS, Suh HW (2010) Characterization of blood glucose level regulation in mouse opioid withdrawal models. Neurosci Lett 476:119–122
Pačesová D, Novotný J, Bendová Z (2016) The effect of chronic morphine or methadone exposure and withdrawal on clock gene expression in the rat suprachiasmatic nucleus and AA-NAT activity in the pineal gland. Physiol Res 65:517–525
Pierce T, Hope W, Raper C (1996) The induction and quantitation of methadone dependence in the rat. J Pharmacol Toxicol Methods 36:137–146
Fenn JM, Laurent JS, Sigmon SC (2015) Increases in body mass index following initiation of methadone treatment. J Subst Abuse Treat 51:59–63
Kolarzyk E, Pach D, Wojtowicz B, Szpanowska-Wohn A, Szurkowska M (2005) Nutritional status of the opiate dependent persons after 4 years of methadone maintenance treatment. Przeglad lekarski 62:373–377
Kheradmand A, Banazadeh N, Abedi H (2010) Physical effects of methadone maintenance treatment from the standpoint of clients. Addict Health 2:66–73
Kolarzyk E, Chrostek Maj J, Pach D, Janik A, Kwiatkowski J, Szurkowska M (2005) Assessment of daily nutrition ratios of opiate-dependent persons before and after 4 years of methadone maintenance treatment. Przegl Lek 62:368–372
Noor S, Alam F, Fatima SS, Khan M, Rehman R (2018) Role of Leptin and dyslipidemia in chronic kidney disease. Pak J Pharm Sci 31:893
Olszewski PK, Levine AS (2007) Central opioids and consumption of sweet tastants: when reward outweighs homeostasis. Physiol Behav 91:506–512
Sadava D, Alonso D, Hong H, Pettit-Barrett D (1997) Effect of methadone addiction on glucose metabolism in rats. Gen Pharm Vasc Syst 28:27–29
Santoro GC, Carrion J, Patel K, Vilchez C, Veith J, Brodie JD, Dewey SL (2017) Sex differences in regional brain glucose metabolism following opioid withdrawal and replacement. Neuropsychopharmacol 42:1841–1849
Lin SH, Yang YK, Lee SY, Hsieh PC, Chen PS, Lu RB, Chen KC (2012) Association between cholesterol plasma levels and craving among heroin users. J Addict Med 6:287–291
Montazerifar, F., Karajibani, M., Lashkaripour, K., Yousefi, M. (2014) Effects of methadone maintenance therapy (MMT) on serum leptin, lipid profile and anthropometric parameters in opioid addicts. Heroin Addict Relat Clin Probl 16(1):9–16
Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, Schön M (2005) Plasma visfatiDn concentrations and fat depot-specific mRNA expression in humans. Diabetes 54:2911–2916
Housova J, Wilczek H, Haluzik MM, Kremen J, Krizova J, Haluzik M (2005) Adipocyte-derived hormones in heroin addicts: the influence of methadone maintenance treatment. Physiol Res 54:73–78
Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Häring H, Stumvoll M (2003) Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239–243